Archive - April 2019
Holobiome and J&J collaborate for second time for microbiome therapeutics
New test could diagnose nine in 10 endometriosis cases
PharmaTimes announce brand new partnership for this year’s Communications Team of the Year Charity Challenge
Merck bags Chinese OK for Keytruda in first-line lung cancer
European approval for Teva’s migraine drug Ajovy
NICE nod for breast cancer delay drug
AZ’s Selumetinib granted US Breakthrough Therapy Designation
Circassia’s COPD drug gets FDA approval
